Hester Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 to consider and approve standalone and consolidated unaudited financial results for the quarter and nine months period ended 31 December 2023.
The above information is a part of company’s filings submitted to BSE.